Clinical Trial Detail

NCT ID NCT01792050
Title Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements yes
Sponsors NewLink Genetics Corporation
Indications

Her2-receptor negative breast cancer

Therapies

Docetaxel

indoximod

Paclitaxel

Age Groups: adult

Additional content available in CKB BOOST